Your Health, We Care
Capmatinib produced by Lucius，200mg*60 tablets:$525.
The price of Capmatinib may be affected by factors such as exchange rates, shipping costs, and production costs.
Capmatinib is a targeted therapy for patients with non-small cell lung cancer with specific gene mutations, with significant efficacy and a relatively good safety profile.What is t···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：132
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyrosine kinase inhibitor that specifically targets the c-Met receptor. Capmatinib has shown durable eff···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：136
Capmatinib inhibits the growth of cancer cells caused by specific genetic variants, i.e., MET exon 14 skipping or MET amplification. These genetic variants are common in tumors suc···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：133
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
